RFWD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.02929886836023E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.48243697504358E-12 |
Normal-vs-Stage2 |
1.54479984360023E-10 |
Normal-vs-Stage3 |
6.07602856916856E-12 |
Normal-vs-Stage4 |
2.49339999980336E-07 |
Stage1-vs-Stage2 |
6.491200E-01 |
Stage1-vs-Stage3 |
4.458600E-01 |
Stage1-vs-Stage4 |
1.576820E-01 |
Stage2-vs-Stage3 |
9.152600E-01 |
Stage2-vs-Stage4 |
1.453350E-01 |
Stage3-vs-Stage4 |
8.216200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.10159667446419E-11 |
Normal-vs-AfricanAmerican |
1.68298708302927E-12 |
Normal-vs-Asian |
1.114430E-01 |
Caucasian-vs-AfricanAmerican |
3.840800E-03 |
Caucasian-vs-Asian |
1.551560E-01 |
AfricanAmerican-vs-Asian |
5.843500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.05504535400314E-12 |
Normal-vs-Female |
1.02370001364704E-10 |
Male-vs-Female |
2.023800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.12060000004399E-07 |
Normal-vs-Age(41-60Yrs) |
1.33330013696309E-10 |
Normal-vs-Age(61-80Yrs) |
5.63371571615789E-12 |
Normal-vs-Age(81-100Yrs) |
1.74790004692227E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.332000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.776200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.979620E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.600960E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.255800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.951610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.53378999999676E-05 |
Normal-vs-Grade 2 |
7.13873404833976E-12 |
Normal-vs-Grade 3 |
2.34330332915533E-11 |
Normal-vs-Grade 4 |
5.34140000008065E-08 |
Grade 1-vs-Grade 2 |
7.294400E-01 |
Grade 1-vs-Grade 3 |
8.432800E-01 |
Grade 1-vs-Grade 4 |
9.736800E-01 |
Grade 2-vs-Grade 3 |
7.449000E-01 |
Grade 2-vs-Grade 4 |
5.992400E-01 |
Grade 3-vs-Grade 4 |
7.268200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.89329720976662E-11 |
Normal-vs-ccB subtype |
2.00217620260901E-12 |
ccA subtype-vs-ccB subtype |
8.165700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.90479965134216E-10 |
Normal-vs-N1 |
1.256440E-02 |
N0-vs-N1 |
3.029200E-01 |
|
|